多参数磁共振成像显示单侧病灶的男性中对侧病变的预测因素
该回顾性研究纳入490例在多参数磁共振成像(MRI)上显示单侧病灶且靶向活检证实为临床显著前列腺癌(csPCa)的男性,评估对侧csPCa的预测因素。多因素逻辑回归显示,既往活检阴性(OR 0.34)与对侧csPCa风险降低相关,而前列腺特异性抗原密度(OR 18.8)和肿瘤位于横断面后部(OR 1.93)或贯穿横断面(OR 6.56)与风险升高相关。约20%的单侧MRI病灶男性在系统活检中发现对侧csPCa。
要点
- 既往活检阴性(OR 0.34 [0.14, 0.75],P = .012)与对侧csPCa风险降低相关。
- 前列腺特异性抗原密度(OR 18.8 [2.77, 249],P = .017)与对侧csPCa风险升高相关。
- 肿瘤位于横断面后部(OR 1.93 [1.02, 3.87],P = .048)或贯穿横断面(OR 6.56 [2.26, 19.6],P < .001)与对侧csPCa风险升高相关。
核心结论
- 约20%的单侧MRI病灶且靶向活检证实csPCa的男性在系统活检中发现对侧csPCa。
- 既往活检阴性与对侧csPCa风险降低相关,前列腺特异性抗原密度和肿瘤位于后部或贯穿横断面与风险升高相关。
- 考虑这些临床因素可能为仅在对侧csPCa风险高时使用系统活检提供机会。
研究设计与样本
- 回顾性识别本机构活检数据库中无前列腺癌病史、MRI PI-RADS 2-5病灶内活检证实为单侧csPCa的男性。
- 采用多因素逻辑回归识别对侧病变的临床预测因素。
- 共490例男性符合纳入标准。
主要发现
- 490例中385例(78.6%)无对侧csPCa,105例(21.4%)有对侧csPCa。
- 既往活检阴性(OR 0.34 [0.14, 0.75],P = .012)与对侧csPCa风险降低独立相关。
- 前列腺特异性抗原密度(OR 18.8 [2.77, 249],P = .017)与对侧csPCa风险升高独立相关。
- 肿瘤位于横断面后部(OR 1.93 [1.02, 3.87],P = .048)或贯穿横断面(OR 6.56 [2.26, 19.6],P < .001)与对侧csPCa风险升高独立相关。
- MRI靶向肿瘤内似乎没有能可靠预测对侧csPCa的特征。
临床怎么用
- 作者认为,考虑这些临床因素可能为仅在对侧csPCa风险高时使用系统活检提供机会。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To evaluate predictors of contralateral clinically significant prostate cancer (csPCa) in men with biopsy-proven unilateral lesions on magnetic resonance imaging (MRI). METHODS: We retrospectively identified men with no prior diagnosis of PCa with unilateral biopsy-confirmed csPCa within PI-RADS 2-5 lesions within our institutional biopsy database. Multivariate logistic regression was used to identify clinical predictors of contralateral disease. RESULTS: Four hundred ninety men met study inclusion criteria, of which 385 men (78.6%) had no contralateral csPCa and 105 men (21.4%) had contralateral csPCa (Fig. 1). Prior negative biopsy (OR 0.34 [0.14, 0.75], P = .012), prostate-specific antigen density (OR 18.8 [2.77, 249], P = .017), and tumor location in the transverse plane ("Posterior": OR 1.93 [1.02, 3.87], P = .048; "Throughout Transverse Plane": OR 6.56 [2.26, 19.6], P < .001) were significantly associated with contralateral csPCa in multivariate logistic regression models. However, there appear to be no attributes within the MRI-targeted tumor that reliably predict contralateral csPCa (Table 2). CONCLUSION: Approximately 20% of men with unilateral MRI findings and csPCa on targeted biopsy were found to have contralateral csPCa on systematic biopsy (SB). Prior negative biopsy was associated with a decreased odds of contralateral csPCa. Prostate-specific antigen density and tumor in the posterior aspect of or throughout the transverse plane were associated with increased odds of contralateral csPCA. Consideration of these clinical factors may afford an opportunity to only use SB in cases in which the odds of contralateral csPCa are high.
引用
- Sawhney V, Huang R, Huang WC, et al. Predictors of Contralateral Disease in Men With Unilateral Lesions on Multiparametric Magnetic Resonance Imaging. Urology. 2024. PMID: 39004105. doi:10.1016/j.urology.2024.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。